Insider · CIK 0001589597

WILSON TROY EDWARD

Reports to the SEC for 5 companies · LOS ANGELES, CA

sec.gov

Transactions

Companies

Filings

CIK

0001589597

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-14	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Director	SSale	−5,000 sh	$9.10	−$45.5K	54,750
2026-08-24	KURAKura Oncology, Inc.P Purchase	Director, President and CEO	PPurchase	+100K sh	$12.39	+$1.24M	479,194
2026-08-17	KURAKura Oncology, Inc.P Purchase	Director, President and CEO	PPurchase	+100K sh	$11.12	+$1.11M	379,194
2026-06-12	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Director	SSale	−10.8K sh	$7.20	−$77.7K	59,750
2026-06-11	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Director	AAward	+27K sh	—	—	70,550
2026-03-23	KURAKura Oncology, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+6,103 sh	$6.15	+$37.5K	435,456
2026-03-23	KURAKura Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+6,103 sh	—	—	0
2026-02-27	RNAAtrium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2026-02-27	RNAMAvidity Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−65.1K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−13.7K sh	—	—	0
2026-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director, President and CEO	AAward	+1.12M sh	—	—	1,120,000
2025-11-13	KURAKura Oncology, Inc.A Award	Director, President and CEO	AAward	+183K sh	—	—	429,353
2025-09-29	KURAKura Oncology, Inc.S Sale	Director, President and CEO	SSale	−36.6K sh	$8.94	−$327K	246,853
2025-09-27	KURAKura Oncology, Inc.A Award	Director, President and CEO	AAward	+183K sh	—	—	283,468
2025-09-08	KURAKura Oncology, Inc.P Purchase	Director, President and CEO	PPurchase	+50K sh	$8.20	+$410K	100,968
2025-09-05	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−14.5K sh	—	—	0
2025-09-05	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.5K sh	$12.48	+$181K	83,925
2025-09-05	RNAMAvidity Biosciences, Inc.S Sale	Director	SSale	−14.5K sh	$50.00	−$725K	69,425
2025-09-05	RNAMAvidity Biosciences, Inc.S Sale	Director	SSale	−15K sh	$50.00	−$750K	54,425
2025-08-13	KURAKura Oncology, Inc.P Purchase	Director, President and CEO	PPurchase	+13.5K sh	$6.64	+$89.6K	50,968
2025-08-12	KURAKura Oncology, Inc.P Purchase	Director, President and CEO	PPurchase	+36.5K sh	$5.85	+$214K	37,474
2025-08-06	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+22K sh	$12.03	+$265K	91,425
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Director	SSale	−7,500 sh	$45.00	−$338K	69,425
2025-08-06	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−22K sh	—	—	0
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Director	SSale	−15K sh	$45.00	−$675K	285,000
2025-08-06	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	14,500
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Director	SSale	−17.8K sh	$45.00	−$800K	17,776
2025-08-06	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$12.48	+$93.6K	76,925
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Director	SSale	−17.8K sh	$45.00	−$800K	17,776
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Director	SSale	−15K sh	$45.00	−$675K	285,000
2025-08-06	RNAMAvidity Biosciences, Inc.S Sale	Director	SSale	−22K sh	$45.00	−$990K	69,425
2025-06-13	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Director	SSale	−10.8K sh	$3.40	−$36.7K	43,550
2025-06-11	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Director	AAward	+27K sh	—	—	54,350
2025-06-10	RNAMAvidity Biosciences, Inc.A Award	Director	AAward	+6,692 sh	—	—	69,425
2025-06-10	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,034
2025-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director, President and CEO	AAward	+625K sh	—	—	625,000
2024-06-18	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Director	AAward	+27K sh	—	—	27,350
2024-06-13	PBYIPUMA BIOTECHNOLOGY, INC.S Sale	Director	SSale	−27K sh	$3.33	−$89.9K	350
2024-06-13	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.5K sh	—	—	13,489
2024-01-24	KURAKura Oncology, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+6,945 sh	$4.80	+$33.3K	7,504
2024-01-24	KURAKura Oncology, Inc.S Sale	Director, President and CEO	SSale	−84.1K sh	$20.23	−$1.7M	559
2024-01-24	KURAKura Oncology, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+84.1K sh	$6.15	+$517K	84,666
2024-01-24	KURAKura Oncology, Inc.S Sale	Director, President and CEO	SSale	−6,945 sh	$20.23	−$140K	559
2024-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director, President and CEO	AAward	+560K sh	—	—	560,000
2023-12-12	RNAMAvidity Biosciences, Inc.J Other	Director	JOther	−300K sh	—	—	263,711
2023-12-12	RNAMAvidity Biosciences, Inc.J Other	Director	JOther	+250K sh	—	—	300,000
2023-12-12	RNAMAvidity Biosciences, Inc.J Other	Director	JOther	−250K sh	—	—	13,711

Recent filings

Accepted (ET)
Sep 164
WILSON TROY EDWARD0001437749-26-030597
SEC(opens sec.gov)
Aug 244
WILSON TROY EDWARD0001193125-26-363812
SEC(opens sec.gov)
Aug 174
WILSON TROY EDWARD0001193125-26-354201
SEC(opens sec.gov)
Jun 154
WILSON TROY EDWARD0001437749-26-020709
SEC(opens sec.gov)
Mar 254
WILSON TROY EDWARD0001193125-26-122938
SEC(opens sec.gov)
Mar 24
WILSON TROY EDWARD0001193125-26-085920
SEC(opens sec.gov)
Feb 274
WILSON TROY EDWARD0001193125-26-082251
SEC(opens sec.gov)
Jan 64
WILSON TROY EDWARD0001193125-26-004580
SEC(opens sec.gov)
Nov 144
WILSON TROY EDWARD0001193125-25-283565
SEC(opens sec.gov)
Sep 294
WILSON TROY EDWARD0001193125-25-223663
SEC(opens sec.gov)
Sep 94
WILSON TROY EDWARD0001599901-25-000177
SEC(opens sec.gov)

Companies

Address

C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BOULEVARD, SUITE 1700

LOS ANGELES, CA, 90024